SMTL ID : 6yb4.1

Crystal structure of human ATAD2 bromodomain in complex with N-(4-bromo-3-(3-methylpyrrolidin-1-yl)sulfonyl)phenyl)-2-(-4-cyclopropyl-4-methyl-2,5-dioxoimidazolidin-1-yl)acetamide

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.85 Å
Oligo State
monomer
Ligands
2 x SO4: SULFATE ION(Non-functional Binders)
3 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
1 x OJH: ~{N}-[4-bromanyl-3-[(3~{S})-3-methylpyrrolidin-1-yl]sulfonyl-phenyl]-2-[(4~{R})-4-cyclopropyl-4-methyl-2,5-bis(oxidanylidene)imidazolidin-1-yl]ethanamide(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Lucas, S.C.C. et al., Optimization of Potent ATAD2 and CECR2 Bromodomain Inhibitors with an Atypical Binding Mode. J.Med.Chem. (2020)
Release Date
2020-05-06
Peptides
ATPase family AAA domain-containing protein 2: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
AAA